Create an alert
to follow the executive moves at CeaPro.

Latest M&A news in Biotechnology.

Merck has announced the acquisition of ArQule (posted on Dec 9, 2019).
Astellas Pharma has announced the acquisition of Audentes Therapeutics (posted on Dec 5, 2019).
Mesa Laboratories has announced the acquisition of Gyros (posted on Nov 1, 2019).

Most searched biographies at CeaPro

• Gilles Gagnon, President, Chief Executive Officer and Director
• John Zupancic, Director
• Glenn Rourke, Chairman of the Board

Click on an executive to view his biography >

Other contacts in the Biotechnology industry

• Fred Cohen - Director at UroGen
• Sylke Hassel - Senior Vice President and Global Head of Mammalian Busines at Lonza
• Fareed Khan - Chief Financial Officer at Parallel

Learn more about the Biotechnology industry >

Latest news about CeaPro

Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting – Results showed that oat avenanthramides supplementation reduce circulatory inflammation and inhibit expressions of chemokines and adhesion molecules – Ceapro

CeaPro on Wikipedia, Google News & Yahoo Finance

CeaPro on LinkedIn, Twitter & YouTube

CeaPro has 1,320 competitors including Alltech (United States (USA)), Aldeyra Therapeutics (United States (USA)) and Charles River Laboratories International (United States (USA)).

Contact by email its executives including Gilles Gagnon

Call CeaPro at +1 780....

View the org chart

Register to receive your alert

Report an error